Reality of obesity paradox: Results of percutaneous coronary intervention in Middle Eastern patients

被引:2
|
作者
Jarrah, Mohamad [1 ]
Hammoudeh, Ayman J. [2 ]
Khader, Yousef [3 ]
Tabbalat, Ramzi [4 ]
Al-Mousa, Eyas [2 ]
Okkeh, Osama [5 ]
Alhaddad, Imad A. [6 ]
Tawalbeh, Loai Issa [7 ]
Hweidi, Issa M. [8 ]
机构
[1] King Abdullah Univ Hosp, Cardiol Sect, Dept Internal Med, Irbid, Jordan
[2] Istishari Hosp, Dept Cardiol, Amman, Jordan
[3] Jordan Univ Sci & Technol, Sch Allied Med Sci, Irbid, Jordan
[4] Khalidi Med Ctr, Dept Cardiol, Amman, Jordan
[5] Arab Med Ctr, Dept Cardiol, Amman, Jordan
[6] Jordan Hosp Med Ctr, Dept Cardiol, Amman, Jordan
[7] AL AlBayt Univ, Fac Nursing, Almafraq, Jordan
[8] Jordan Univ Sci & Technol, Fac Nursing, Irbid, Jordan
关键词
Cardiovascular disease; obesity; obesity paradox; Middle Eastern patients; percutaneous coronary intervention; major adverse cardiovascular events; BODY-MASS INDEX; ACUTE MYOCARDIAL-INFARCTION; ALL-CAUSE MORTALITY; LONG-TERM OUTCOMES; SCIENTIFIC STATEMENT; DIABETES-MELLITUS; ARTERY-DISEASE; WEIGHT-GAIN; RISK; ASSOCIATION;
D O I
10.1177/0300060518757354
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective The aim of this study was to assess the baseline clinical characteristics, coronary angiographic features, and adverse cardiovascular events during hospitalization and at 1 year of follow-up in obese patients compared with overweight and normal/underweight patients. Methods A prospective, multicenter study of consecutive patients undergoing percutaneous coronary intervention was performed. Results Of 2425 enrolled patients, 699 (28.8%) were obese, 1178 (48.6%) were overweight, and 548 (22.6%) were normal/underweight. Obese patients were more likely to be female and to have a higher prevalence of diabetes, hypertension, hypercholesterolemia, or previous percutaneous coronary intervention. Acute coronary syndrome was the indication for percutaneous coronary intervention in 77.0% of obese, 76.4% of overweight, and 77.4% of normal/underweight patients. No significant differences in the prevalence of multi-vessel coronary artery disease or multi-vessel percutaneous coronary intervention were found among the three groups. Additionally, no significant differences were found in stent thrombosis, readmission bleeding rates, or cardiac mortality among the three groups during hospitalization, at 1 month, and at 1 year. Conclusion The major adverse cardiovascular event rate was the same among the three groups throughout the study period. Accordingly, body mass index is considered a weak risk factor for cardiovascular comorbidities in Arab Jordanian patients.
引用
收藏
页码:1595 / 1605
页数:11
相关论文
共 50 条
  • [1] Obesity paradox in patients with coronary artery disease treated with percutaneous coronary intervention
    Youn, Y. J.
    Lee, J. W.
    Ahn, S. G.
    Ahn, M. S.
    Kim, J. Y.
    Yoo, B. S.
    Lee, S. H.
    Yoon, J.
    EUROPEAN HEART JOURNAL, 2015, 36 : 917 - 917
  • [2] The obesity paradox of mortality in patients with coronary artery disease undergoing percutaneous coronary intervention
    Lin, Gen-Min
    Li, Yi-Hwei
    Jaiteh, Lamin E. S.
    Han, Chih-Lu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (02) : 597 - 597
  • [3] Obesity paradox in asian patients with coronary artery disease after percutaneous coronary intervention
    Kaneko, H.
    Yajima, J.
    Oikawa, Y.
    Tanaka, S.
    Fukamachi, D.
    Suzuki, S.
    Matsuno, S.
    Kano, H.
    Aizawa, T.
    Yamashita, T.
    EUROPEAN HEART JOURNAL, 2013, 34 : 804 - 805
  • [4] Percutaneous Coronary Intervention and the Obesity Paradox Fat Chance
    Savage, Michael P.
    Fischman, David L.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (01) : 77 - 79
  • [5] Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention
    Hastie, Claire E.
    Padmanabhan, Sandosh
    Slack, Rachel
    Pell, Alastair C. H.
    Oldroyd, Keith G.
    Flapan, Andrew D.
    Jennings, Kevin P.
    Irving, John
    Eteiba, Hany
    Dominiczak, Anna F.
    Pell, Jill P.
    EUROPEAN HEART JOURNAL, 2010, 31 (02) : 222 - 226
  • [6] Evaluation of paradoxic beneficial effect of obesity in patients undergoing percutaneous coronary intervention: The obesity paradox?
    Gruberg, L
    Mehran, R
    Dangas, G
    Satler, LF
    Wu, HS
    Gevorkian, N
    Einav-Gruberg, R
    Purser, A
    Pichard, AD
    Kent, KM
    Waksman, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 22A - 22A
  • [7] The Obesity Paradox in Coronary Patients: Myth or Reality?
    Santarpino, Giuseppe
    Pfeiffer, Steffen
    Fischlein, Theodor
    ANNALS OF THORACIC SURGERY, 2011, 92 (03): : 1154 - 1155
  • [8] Obesity paradox in Japanese patients after percutaneous coronary intervention: An observation cohort study
    Kaneko, Hidehiro
    Yajima, Junji
    Oikawa, Yuji
    Tanaka, Shingo
    Fukamachi, Daisuke
    Suzuki, Shinya
    Sagara, Koichi
    Otsuka, Takayuki
    Matsuno, Shunsuke
    Funada, Ryuichi
    Kano, Hiroto
    Uejima, Tokuhisa
    Koike, Akira
    Nagashima, Kazuyuki
    Kirigaya, Hajime
    Sawada, Hitoshi
    Aizawa, Tadanori
    Yamashita, Takeshi
    JOURNAL OF CARDIOLOGY, 2013, 62 (1-2) : 18 - 24
  • [9] Impact of obesity on cardiovascular outcomes in patients undergoing percutaneous coronary intervention: Is there really a paradox?
    Ahmed, AS
    Murtaza, M
    Catchings, T
    Webel, R
    Shaw, R
    Flaker, GC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 80A - 80A
  • [10] Exploring the mechanistic basis for the obesity paradox in patients undergoing percutaneous coronary intervention for coronary artery disease
    Shields, M.
    Crowe, C.
    Crowley, J.
    Finucane, F. M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 : S459 - S460